Lululemon Successfully Appeals $355,000 Verdict in Nike Flyknit Patent Case

Tuesday, March 31, 2026iiplaeditorialSource: IIPLA
lululemon-successfully-appeals-355-000-v.png
Source attribution
Image: Image courtesy of iipla.org

Lululemon Successfully Appeals $355,000 Verdict in Nike Flyknit Patent Case

By Editorial Team

Lululemon USA Inc. has emerged victorious in its legal battle against Nike Inc. over patent infringement claims related to knit sneakers. A federal judge recently overturned a jury verdict that initially ordered Lululemon to pay $355,000 in damages to Nike.

The dispute centered around parts of Nike’s US Patent No. 8,266,749, which the jury believed Lululemon had infringed upon. However, Judge Arun Subramanian of the US District Court for the Southern District of New York ruled that these specific patent claims were invalid due to being obvious.

In his opinion, Judge Subramanian stated that Nike is not entitled to any damages from Lululemon. The court not only nullified the damages award but also dismissed Nike’s request to increase the amount.

The initial jury verdict, issued in March 2025, has now been overturned in favor of Lululemon following the judge's decision.

For more legal news and analysis, visit Bloomberg Law for comprehensive coverage and insights on current events.

Related Coverage

Continue in the newsroom

Back to newsroom
IP News

Purple Rain Co-Star Ends Apollonia Trademark Rights Suit

‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...

Thursday, April 9, 2026
IP News

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct By Editorial Team A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...

Thursday, April 9, 2026
IP News

J&J Defends Blood-Clotting Powder IP From Baxter Attack

J&J Defends Blood-Clotting Powder IP From Baxter Attack By Editorial Team A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...

Thursday, April 9, 2026